PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis

被引:264
作者
Li, AC [1 ]
Glass, CK [1 ]
机构
[1] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA
关键词
peroxisome proliferator-activated receptors; liver X receptors; foam cell formation;
D O I
10.1194/jlr.R400010-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nuclear receptor superfamily is composed of transcription factors that positively and negatively regulate gene expression in response to the binding of a diverse array of lipid-derived hormones and metabolites. Intense efforts are currently being directed at defining the biological roles and mechanisms of action of liver X receptors (LXRs) and peroxisome proliferator-activated receptors (PPARs). LXRs have been found to play essential roles in the regulation of whole body cholesterol absorption and excretion, in the efflux of cholesterol from peripheral cells, and in the biosynthesis and metabolism of very low density lipoproteins. PPARs have been found to regulate diverse aspects of lipid metabolism, including fatty acid oxidation, fat cell development, lipoprotein metabolism, and glucose homeostasis. Intervention studies indicate that activation of PPARalpha, PPARgamma, and LXRs by specific synthetic ligands can inhibit the development of atherosclerosis in animal models. Here, we review recent studies that provide new insights into the mechanisms by which these subclasses of nuclear receptors act to systemically influence lipid and glucose metabolism and regulate gene expression within the artery wall.-Li, A. C., and C. K. Glass. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis.
引用
收藏
页码:2161 / 2173
页数:13
相关论文
共 147 条
  • [1] Attie AD, 2001, J LIPID RES, V42, P1717
  • [2] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [3] Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the litigation of PPARγ
    Bell-Parikh, LC
    Ide, T
    Lawson, JA
    McNamara, P
    Reilly, M
    FitzGerald, GA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) : 945 - 955
  • [4] Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
    Berthou, L
    Duverger, N
    Emmanuel, F
    Langouet, S
    Auwerx, J
    Guillouzo, A
    Fruchart, JC
    Rubin, E
    Denefle, P
    Staels, B
    Branellec, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2408 - 2416
  • [5] Boullier A, 2001, ANN NY ACAD SCI, V947, P214
  • [6] Differential activation of adipogenesis by multiple PPAR isoforms
    Brun, RP
    Tontonoz, P
    Forman, BM
    Ellis, R
    Chen, J
    Evans, RM
    Spiegelman, BM
    [J]. GENES & DEVELOPMENT, 1996, 10 (08) : 974 - 984
  • [7] Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages
    Castrillo, A
    Joseph, SB
    Marathe, C
    Mangelsdorf, DJ
    Tontonoz, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) : 10443 - 10449
  • [8] PPARγ is a very low-density lipoprotein sensor in macrophages
    Chawla, A
    Lee, CH
    Barak, Y
    He, WM
    Rosenfeld, J
    Liao, D
    Han, J
    Kang, H
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) : 1268 - 1273
  • [9] A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
    Chawla, A
    Boisvert, WA
    Lee, CH
    Laffitte, BA
    Barak, Y
    Joseph, SB
    Liao, D
    Nagy, L
    Edwards, PA
    Curtiss, LK
    Evans, RM
    Tontonoz, P
    [J]. MOLECULAR CELL, 2001, 7 (01) : 161 - 171
  • [10] PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
    Chawla, A
    Barak, Y
    Nagy, L
    Liao, D
    Tontonoz, P
    Evans, RM
    [J]. NATURE MEDICINE, 2001, 7 (01) : 48 - 52